Hamilton Lane reported a record quarterly revenue of $275.3 million, up 56% year-over-year, driven by a 21% increase in management and advisory fees. Insiders bought $4.2 million of stock in June, and the board raised the dividend target by 11%, signaling confidence in future growth. The stock trades at a relatively low valuation of 15.7 times trailing earnings, about half that of peers Blackstone and KKR, while delivering the highest shareholder income conversion at 32% of revenue. Avalon Capital Research rates Hamilton Lane as a BUY with a price target of $128, about 24% above the current price as of September 4.
On September 4, 2026, major tech stocks including TurboGen Ltd., Pasqal Holding, Guidewire Software, eGain Corporation, and Lululemon Athletica saw significant declines. Newly listed companies TurboGen and Pasqal experienced sharp post-listing volati...
American Outdoor Brands (AOUT), Quanex Building Products (NX), and bioAffinity Technologies (BIAF) saw significant stock price gains driven by strong earnings reports, improved financial guidance, and key company announcements. AOUT surged nearly 45%...
Alico, Inc. reports a Return on Invested Capital (ROIC) of 7.29%, slightly below its Weighted Average Cost of Capital (WACC) of 7.96%, resulting in an ROIC-to-WACC ratio of 0.92. This indicates the company is close to covering its capital costs but n...
DigitalOcean CEO Padmanabhan Srinivasan sold 20,483 shares of the company, generating $2.2 million from the transaction. This insider sale may indicate personal financial planning or a strategic move, but it does not necessarily reflect the company's...
Injective has emerged as a leading layer-1 blockchain platform after Pineapple Financial tokenized over $1 billion in residential mortgage records on its network. This milestone highlights Injective's growing role in the asset tokenization space, mak...
